Activation of G-proteins in the mouse pons/medulla by β-endorphin is mediated by the stimulation of μ- and putative ε-receptors

Life Sciences

Volumn 67, Issue 22, 2000, Pages 2733-2743

  Mizoguchi, Hirokazu ^a   Narita, Minoru ^a,b   Nagase, Hiroshi ^c   Tseng, Leon F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b HOSHI UNIVERSITY   (Japan)

^c TORAY INDUSTRIES INC   (Japan)

Author keywords

G proteins; Mouse; Pons medulla; Putative opioid receptors; 35S GTP S binding; Endorphin

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BETA ENDORPHIN; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; EPSILON OPIATE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE PEPTIDE;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; BRAIN REGION; MALE; MEDULLA OBLONGATA; MOUSE; NONHUMAN; PONS; PROTEIN DETERMINATION;

ANIMALIA;

EID: 0034692919     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00852-3     Document Type: Article

References (49)

1. Receptor-effector coupling by G proteins
2. G proteins: Transducers of receptor-generated signals
3. 2+ and the βγ-subunit complex on the interactions of guanine nucleotides with G proteins
4. 4
5. 35S]thio)triphosphate binding
6. 2-adrenergic receptor activation of G-proteins: Evidence for a precoupled receptor/G protein state
7. 4.4 receptors: Actions of antiparkinsonian and antipsychotic agents
8. 35S]guanosine-5'-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography
9. 35S]thio]triphosphate binding
10. 35S]GTPγS binding in the mouse spinal cord
11. Absence of G-protein activation by μ-opioid receptor agonists in the spinal cord of μ-opioid receptor knockout mice
12. Opioid receptor-coupled G-protein in rat locus coeruleus membranes: Decrease in activity after chronic morphine treatment
13. μ-Opioid receptor-stimulated guanosine-5'-O-(γ-thio)triphosphate binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy
14. 35S]GTPγS autoradiography in rat brain
15. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells
16. 35S]thio)triphosphate to NG108-15 cell membranes: Characterization of agonist and inverse agonist effects
17. 35S]GTPγS binding to membranes: Determination of potencies and efficacies of ligands
18. β-Endorphin is a potent analgesic agent
19. β-Endorphin as a potent analgesic by intravenous injection
20. The role of amino-terminal sequence of β-endorphin and dynorphin in the determination of opioid receptor type selectivity
21. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors
22. Opioid receptors
23. Intrathecal β-funaltrexamine antagonizes intracerebroventricular β-endorphin- but not morphine-induced analgesia in mice
24. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and β-endorphin in mice
25. Release of immunoreactive Met-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized rats
26. Release of immunoreactive met-enkephalin by intraventricular beta-endorphin in anesthetized rats
27. Spinal release of immunoreactive Met-enkephalin by intraventricular beta-endorphin and its analogs in anesthetized rats
28. 1 opioid receptors are involved in intracerebroventricular β-endorphin-induced antinociception in the mouse
29. 5]enkephalin antibody blocks analgesia induced by intracerebroventricular β-endorphin but not morphine in mice
30. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by β-endorphin given intracerebroventricularly in mice
31. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse
32. Differential mechanisms mediating β-endorphin-and morphine-induced analgesia in mice
33. Intrathecal DSP-4, 6-hydroxydopamine and 5,7-dihydroxytryptamine differentiate intracerebroventricular β-endorphin- from morphine-induced antinociception in the mouse
34. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered β-endorphin and morphine or DPDPE in mice
35. 3H]β-endorphin binding in brain
36. 3H]-β-Endorphin binding in rat brain
37. Antagonist-induced up-regulation of the putative epsilon opioid receptor in rat brain: Comparison with kappa, mu and delta opioid receptors
38. Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: The U-69,593-insensitive site appears to be the beta-endorphin-specific epsilon receptor
39. Properties of the putative epsilon opioid receptor: Identification in rat, guinea pig, cow, pig and chicken brain
40. Anatomy of CNS opioid receptors
41. Autoradiography of [3H]U-69593 binding sites in rat brain: Evidence for κ opioid receptor subtypes
42. Neuroanatomical patterns of the μ, δ, and κ opioid receptors of rat brain as determined by quantitative in vitro autoradiography
43. 2 opioid receptors
44. Gx/z is regulated by μ but not δ opioid receptors in the stimulation of the low Km GTPase activity in mouse periaqueductal grey matter
45. β-Endorphin-(1-27) antagonizes β-endorphin- but not morphine-, D-Pen2-D-Pen5-enkephalin- and U50,488H-induced analgesia in mice
46. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse
47. Involvement of supraspinal ε and μ opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse
48. Selective receptors for β-endorphin on the rat vas deferens
49. Pharmacological characterization of the ε-opioid receptor